Is Marketing the Enemy of Pharmaceutical Innovation?

TitleIs Marketing the Enemy of Pharmaceutical Innovation?
Publication TypeJournal Article
Year of Publication2009
AuthorsApplbaum, K
JournalHastings Center Report
PublisherHastings Center
Publication Languageeng
ISSN Number00930334
KeywordsBIOETHICS , business , Essay , marketing , Marketing Ethics , MEDICINE , OUTCOME , Pharmaceutical , Physicians , research , Technological
AbstractAn essay is presented on the relationship between the decline in innovation in the pharmaceutical industry and the increase in marketing. An overview of precommercial planning and marketing is provided. The idea of integrating marketing and research and development has been explored since the 1990s. Physicians are encouraged to seek the help of pharmaceutical industry marketers in assessing treatment outcomes, devising schemes for treatment adherence, and in the delivery of medicines to patients who need them.
NotesHastings Center ReportAccession Number: 43445993; APPLBAUM, KALMAN 1; Affiliation: 1: Medical anthropology and global studies, University of Wisconsin-Milwaukee; Source Info: Jul2009, Vol. 39 Issue 4, p13; Subject Term: ESSAY (Literary form); Subject Term: PHARMACEUTICAL industry; Subject Term: MARKETING; Subject Term: TECHNOLOGICAL innovations; Subject Term: RESEARCH & development; Subject Term: PHYSICIANS; Subject Term: OUTCOME assessment (Medical care); NAICS/Industry Codes: 325412 Pharmaceutical Preparation Manufacturing; NAICS/Industry Codes: 621111 Offices of Physicians (except Mental Health Specialists); Number of Pages: 5p; Document Type: Essay
Full Text